Yahoo
KSE - Delayed Quote KRW

Kolon Corporation (002020.KS)

20,400.00 +900.00 (+4.62%)
At close: 3:30:30 PM GMT+9
Chart Range Bar
Loading chart for 002020.KS
  • Previous Close 19,500.00
  • Open 19,340.00
  • Bid 20,300.00 x --
  • Ask 20,200.00 x --
  • Day's Range 19,210.00 - 20,500.00
  • 52 Week Range 19,190.00 - 88,200.00
  • Volume 26,866
  • Avg. Volume 38,996
  • Market Cap (intraday) 286.762B
  • Beta (5Y Monthly) 1.02
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date (est.) --
  • Forward Dividend & Yield 550.00 (2.82%)
  • Ex-Dividend Date Mar 12, 2026
  • 1y Target Est 100,000.00

Kolon Corporation engages in market research and management consulting, and intellectual property licensing businesses in South Korea and internationally. The company provides tire cords, airbags, PET spunbond, industrial yarns, chamude, humidity control devices, films, IT chemicals, and petroleum resins, as well as aramid, MEA, PEM, DFR, and CPI products; and golf wear, men's and women's apparel, and accessories. It also trades in steel, natural resources, and chemicals; and constructs buildings, housing, plants, as well as undertakes civil engineering and environmental projects. In addition, the company produces car seat fabrics, modules, and artificial turf; engineering plastics, including PA, PBT, and POM; base and compound resins; and aircraft external fuel tanks, airframe structures, engine vanes, submarine non-pressure hulls, sonar domes, acoustic windows, guided weapon launchers and flame treatment devices, personal bulletproof boards, system bulletproof structures, satellite and satellite projectile structures, combustion tubes, and KGGB products. Further, it provides IT services; supplies hardware and software solutions; manages hotels, condominiums, and golf resorts; develops real estate properties; and operates a shopping mall, a pet theme park, and themed toilets. Additionally, the company offers over-the-counter medicines; TRAMOL sustained relief, a painkiller and anti-inflammatory; active pharmaceutical ingredients; and Tissuegene and other biopharmaceuticals, as well as operates drugstores under the W-Store name. the company also imports and sells cars. It also operates Sweet Meal, a café that offers choux, coffee, cheesecakes, and beverages; sells antimicrobial products; and provides automobile sales and repair services. Kolon Corporation was founded in 1957 and is headquartered in Gwacheon-si, South Korea.

www.kolon.com

81

Full Time Employees

December 31

Fiscal Year Ends

Industrials

Sector

Conglomerates

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

002020.KS
58.81%
KOSPI Composite Index (^KS11)
39.03%

1-Year Return

002020.KS
52.77%
KOSPI Composite Index (^KS11)
42.64%

3-Year Return

002020.KS
35.01%
KOSPI Composite Index (^KS11)
150.05%

5-Year Return

002020.KS
31.56%
KOSPI Composite Index (^KS11)
94.43%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 15.68B
Earnings --
Profit Margin 0.00%

Q3

FY17

Q4

FY17

Q1

FY26

Q2

FY26

0
200B
400B
600B
800B
1T
1T
0.0%
1.0%
2.0%
3.0%

Analyst Insights

View More

Analyst Price Targets

100,000.00
100,000.00 Average
20,400.00 Current
100,000.00 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.14%

  • Return on Assets (ttm)

    0.88%

  • Return on Equity (ttm)

    -7.17%

  • Revenue (ttm)

    6.2T

  • Net Income Avi to Common (ttm)

    -60.35B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    361.52B

  • Total Debt/Equity (mrq)

    99.57%

  • Levered Free Cash Flow (ttm)

    51.73B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: